Curaleaf International
Medical cannabis cultivation, manufacturing and distribution for patients, clinics and pharmacies in Europe and beyond
Highlights
- New on EvolcAdded 2026-10-28
About Curaleaf International
Curaleaf International develops and supplies EU GMP-certified medical cannabis products, covering cultivation, extraction, manufacturing, registration, import and distribution. It also runs an online medical cannabis pharmacy and a medical cannabis clinic network in the UK, and has acquired a clinic group in Poland.
Its customers include clinics, pharmacies, healthcare professionals and patients; the company supplies clinics and pharmacies worldwide and offers a UK pathway from prescription to direct delivery. It is a division of Curaleaf Holdings Inc., a US cannabis business.
The company was founded in 2018 under the name EMMAC Life Sciences, and is headquartered in London. It has facilities in Canada and Portugal, distribution in more than 15 countries including Europe, Australia and New Zealand, and launched its Curaleaf Education platform for healthcare professionals in the UK and Poland.
Product: EU GMP-certified medical cannabis products, distribution and registration services, UK online medical cannabis pharmacy, and medical cannabis clinics.
Jobs at Curaleaf International
Leadership
- Boris Jordan · Chairman and CEOSource: company website
- Juan Martinez · CEO, InternationalSource: company website
- Ilya Gruzdev · Chief Financial OfficerSource: company website
- Kelly-Marie Bradbury · HR DirectorSource: company website
- Phil Jones · Chief Technology OfficerSource: company website
More biotech & pharma companies
Cycle Pharmaceuticals
Rare disease medicines and patient support programmes for oncology, neurology, metabolic and immunology conditionsNew on EvolcRemote-friendlyCyden
Manufacturer of energy-based at-home skin and hair devices for consumer and professional beauty marketsNew on EvolcDna Worldwide Group Holdings
DNA testing and related forensic services for individuals, families, immigration applicants and legal casesYoung companyNew on EvolcDnae Group Holdings
Point-of-need semiconductor DNA sequencing diagnostics for infection testing in hospital settings, developed in LondonNew on EvolcDraig Therapeutics
Develops neuropsychiatric drug therapies for patients with depression and other brain disordersNew on EvolcDuke Street Bio
Develops cancer therapies targeting DNA damage repair deficiencies for patients with cancerNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Elementor
- Google Tag Manager
- Google reCAPTCHA
- PHP
- WordPress
- jQuery
